Estimating the Potential Annual Welfare Impact of Innovative Drugs in Use in Switzerland

por Pavic, Matea, Pfeil, Alena M., Szucs, Thomas D.
Publicado 2014

Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C

por Pfeil, Alena M., Reich, Oliver, Guerra, Ines M., Cure, Sandrine, Negro, Francesco, Müllhaupt, Beat, Lavanchy, Daniel, Schwenkglenks, Matthias
Publicado 2015

Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the...

por Gutzwiller, Florian S., Pfeil, Alena M., Ademi, Zanfina, Blank, Patricia R., Braunhofer, Peter G., Szucs, Thomas D., Schwenkglenks, Matthias
Publicado 2015

Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related...

por Lothgren, Mickael, Ribnicsek, Erna, Schmidt, Louise, Habacher, Wolfgang, Lundkvist, Jonas, Pfeil, Alena M, Biteeva, Irina, Vrouchou, Polina, Bracco, Andrea
Publicado 2013

Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genet...

por Pfeil, Alena M, Vulsteke, Christof, Paridaens, Robert, Dieudonné, Anne-Sophie, Pettengell, Ruth, Hatse, Sigrid, Neven, Patrick, Lambrechts, Diether, Szucs, Thomas D, Schwenkglenks, Matthias, Wildiers, Hans
Publicado 2014